Table 2 Demographics and Baseline Clinical Characteristics (ITT Analysis group)
Demographics | Study 0092 ITT Analysis group (N = 392) |
|---|---|
Age | |
Mean (SD) | 45.7 (10.6) |
18-45 years, n (%) | 179 (45.7) |
46-65 years, n (%) | 213 (54.3) |
Gender, n (%) | |
Male | 23 (5.9) |
Female | 369 (94.1) |
Race, n (%) | |
Caucasian | 324 (82.7) |
Black or African American | 51 (13.0) |
Asian | 2 (0.5) |
American Indian or Alaska Native | 3 (0.8) |
Native Hawaiian or other Pacific Islander | 1 (0.3) |
Multiple | 9 (2.3) |
Other | 2 (0.5) |
Duration of Fibromyalgia | |
N | 391 |
Mean (SD) | 7.2 (6.77) |
Median; Min, Max | 5.2; 0.0, 44.0 |
GFI Score at Baseline | |
N | 384 |
Mean (SD) | 33.4 (8.09) |
Median; Min, Max | 34.4; 1.0, 49.4 |
Baseline Pain-NRS | |
N | 392 |
Mean (SD) | 6.1 (1.31) |
Median; Min, Max | 6.0; 3.3, 10.0 |
Baseline FIQ Total Score | |
N | 384 |
Mean (SD) | 54.9 (14.92) |
Median; Min, Max | 55; 12.0, 91.7 |